Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

BUY
$25.86 - $46.71 $751,801 - $1.36 Million
29,072 Added 299.31%
38,785 $1.8 Million
Q1 2023

Apr 28, 2023

SELL
$26.05 - $32.31 $179,484 - $222,615
-6,890 Reduced 41.5%
9,713 $278,000
Q4 2022

Feb 02, 2023

BUY
$19.77 - $42.23 $328,241 - $701,144
16,603 New
16,603 $518,000
Q2 2022

Jul 29, 2022

BUY
$13.19 - $22.1 $111,178 - $186,280
8,429 New
8,429 $131,000

Others Institutions Holding DICE

About DICE Therapeutics, Inc.


  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.